Global Metabotropic Glutamate Antagonists Market Research Report 2024(Status and Outlook)
Report Overview
Metabotropic Glutamate Antagonists act by inhibiting the activity of glutamate receptors in the brain. These receptors are broadly divided into two major subtypes: N-methyl-D-aspartate (NMDA) and 3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
This report provides a deep insight into the global Metabotropic Glutamate Antagonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Metabotropic Glutamate Antagonists Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Metabotropic Glutamate Antagonists market in any manner.
Global Metabotropic Glutamate Antagonists Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc.
NeurOp Inc.
UCB SA
Novartis AG
Luc Therapeutics Inc.
Evotec AG
Market Segmentation (by Type)
Ionic
Non Ionic
Market Segmentation (by Application)
Hospitals And Clinics
Research Institutes
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Metabotropic Glutamate Antagonists Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Metabotropic Glutamate Antagonists act by inhibiting the activity of glutamate receptors in the brain. These receptors are broadly divided into two major subtypes: N-methyl-D-aspartate (NMDA) and 3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
This report provides a deep insight into the global Metabotropic Glutamate Antagonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Metabotropic Glutamate Antagonists Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Metabotropic Glutamate Antagonists market in any manner.
Global Metabotropic Glutamate Antagonists Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc.
NeurOp Inc.
UCB SA
Novartis AG
Luc Therapeutics Inc.
Evotec AG
Market Segmentation (by Type)
Ionic
Non Ionic
Market Segmentation (by Application)
Hospitals And Clinics
Research Institutes
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Metabotropic Glutamate Antagonists Market
- Overview of the regional outlook of the Metabotropic Glutamate Antagonists Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Metabotropic Glutamate Antagonists Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Metabotropic Glutamate Antagonists
1.2 Key Market Segments
1.2.1 Metabotropic Glutamate Antagonists Segment by Type
1.2.2 Metabotropic Glutamate Antagonists Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Metabotropic Glutamate Antagonists Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Metabotropic Glutamate Antagonists Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Metabotropic Glutamate Antagonists Sales by Manufacturers (2019-2024)
3.2 Global Metabotropic Glutamate Antagonists Revenue Market Share by Manufacturers (2019-2024)
3.3 Metabotropic Glutamate Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Metabotropic Glutamate Antagonists Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Metabotropic Glutamate Antagonists Sales Sites, Area Served, Product Type
3.6 Metabotropic Glutamate Antagonists Market Competitive Situation and Trends
3.6.1 Metabotropic Glutamate Antagonists Market Concentration Rate
3.6.2 Global 5 and 10 Largest Metabotropic Glutamate Antagonists Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 METABOTROPIC GLUTAMATE ANTAGONISTS INDUSTRY CHAIN ANALYSIS
4.1 Metabotropic Glutamate Antagonists Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF METABOTROPIC GLUTAMATE ANTAGONISTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Metabotropic Glutamate Antagonists Sales Market Share by Type (2019-2024)
6.3 Global Metabotropic Glutamate Antagonists Market Size Market Share by Type (2019-2024)
6.4 Global Metabotropic Glutamate Antagonists Price by Type (2019-2024)
7 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Metabotropic Glutamate Antagonists Market Sales by Application (2019-2024)
7.3 Global Metabotropic Glutamate Antagonists Market Size (M USD) by Application (2019-2024)
7.4 Global Metabotropic Glutamate Antagonists Sales Growth Rate by Application (2019-2024)
8 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET SEGMENTATION BY REGION
8.1 Global Metabotropic Glutamate Antagonists Sales by Region
8.1.1 Global Metabotropic Glutamate Antagonists Sales by Region
8.1.2 Global Metabotropic Glutamate Antagonists Sales Market Share by Region
8.2 North America
8.2.1 North America Metabotropic Glutamate Antagonists Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Metabotropic Glutamate Antagonists Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Metabotropic Glutamate Antagonists Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Metabotropic Glutamate Antagonists Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Metabotropic Glutamate Antagonists Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Artemis Neuroscience
9.1.1 Artemis Neuroscience Metabotropic Glutamate Antagonists Basic Information
9.1.2 Artemis Neuroscience Metabotropic Glutamate Antagonists Product Overview
9.1.3 Artemis Neuroscience Metabotropic Glutamate Antagonists Product Market Performance
9.1.4 Artemis Neuroscience Business Overview
9.1.5 Artemis Neuroscience Metabotropic Glutamate Antagonists SWOT Analysis
9.1.6 Artemis Neuroscience Recent Developments
9.2 VistaGen Therapeutics
9.2.1 VistaGen Therapeutics Metabotropic Glutamate Antagonists Basic Information
9.2.2 VistaGen Therapeutics Metabotropic Glutamate Antagonists Product Overview
9.2.3 VistaGen Therapeutics Metabotropic Glutamate Antagonists Product Market Performance
9.2.4 VistaGen Therapeutics Business Overview
9.2.5 VistaGen Therapeutics Metabotropic Glutamate Antagonists SWOT Analysis
9.2.6 VistaGen Therapeutics Recent Developments
9.3 Rottapharm Madaus
9.3.1 Rottapharm Madaus Metabotropic Glutamate Antagonists Basic Information
9.3.2 Rottapharm Madaus Metabotropic Glutamate Antagonists Product Overview
9.3.3 Rottapharm Madaus Metabotropic Glutamate Antagonists Product Market Performance
9.3.4 Rottapharm Madaus Metabotropic Glutamate Antagonists SWOT Analysis
9.3.5 Rottapharm Madaus Business Overview
9.3.6 Rottapharm Madaus Recent Developments
9.4 Amorsa Therapeutics
9.4.1 Amorsa Therapeutics Metabotropic Glutamate Antagonists Basic Information
9.4.2 Amorsa Therapeutics Metabotropic Glutamate Antagonists Product Overview
9.4.3 Amorsa Therapeutics Metabotropic Glutamate Antagonists Product Market Performance
9.4.4 Amorsa Therapeutics Business Overview
9.4.5 Amorsa Therapeutics Recent Developments
9.5 Newron Pharmaceuticals
9.5.1 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Basic Information
9.5.2 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product Overview
9.5.3 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product Market Performance
9.5.4 Newron Pharmaceuticals Business Overview
9.5.5 Newron Pharmaceuticals Recent Developments
9.6 Purdue Biopharma
9.6.1 Purdue Biopharma Metabotropic Glutamate Antagonists Basic Information
9.6.2 Purdue Biopharma Metabotropic Glutamate Antagonists Product Overview
9.6.3 Purdue Biopharma Metabotropic Glutamate Antagonists Product Market Performance
9.6.4 Purdue Biopharma Business Overview
9.6.5 Purdue Biopharma Recent Developments
9.7 Relmada Therapeutics
9.7.1 Relmada Therapeutics Metabotropic Glutamate Antagonists Basic Information
9.7.2 Relmada Therapeutics Metabotropic Glutamate Antagonists Product Overview
9.7.3 Relmada Therapeutics Metabotropic Glutamate Antagonists Product Market Performance
9.7.4 Relmada Therapeutics Business Overview
9.7.5 Relmada Therapeutics Recent Developments
9.8 BioCrea GmbH
9.8.1 BioCrea GmbH Metabotropic Glutamate Antagonists Basic Information
9.8.2 BioCrea GmbH Metabotropic Glutamate Antagonists Product Overview
9.8.3 BioCrea GmbH Metabotropic Glutamate Antagonists Product Market Performance
9.8.4 BioCrea GmbH Business Overview
9.8.5 BioCrea GmbH Recent Developments
9.9 Cerecor Inc.
9.9.1 Cerecor Inc. Metabotropic Glutamate Antagonists Basic Information
9.9.2 Cerecor Inc. Metabotropic Glutamate Antagonists Product Overview
9.9.3 Cerecor Inc. Metabotropic Glutamate Antagonists Product Market Performance
9.9.4 Cerecor Inc. Business Overview
9.9.5 Cerecor Inc. Recent Developments
9.10 NeurOp Inc.
9.10.1 NeurOp Inc. Metabotropic Glutamate Antagonists Basic Information
9.10.2 NeurOp Inc. Metabotropic Glutamate Antagonists Product Overview
9.10.3 NeurOp Inc. Metabotropic Glutamate Antagonists Product Market Performance
9.10.4 NeurOp Inc. Business Overview
9.10.5 NeurOp Inc. Recent Developments
9.11 UCB SA
9.11.1 UCB SA Metabotropic Glutamate Antagonists Basic Information
9.11.2 UCB SA Metabotropic Glutamate Antagonists Product Overview
9.11.3 UCB SA Metabotropic Glutamate Antagonists Product Market Performance
9.11.4 UCB SA Business Overview
9.11.5 UCB SA Recent Developments
9.12 Novartis AG
9.12.1 Novartis AG Metabotropic Glutamate Antagonists Basic Information
9.12.2 Novartis AG Metabotropic Glutamate Antagonists Product Overview
9.12.3 Novartis AG Metabotropic Glutamate Antagonists Product Market Performance
9.12.4 Novartis AG Business Overview
9.12.5 Novartis AG Recent Developments
9.13 Luc Therapeutics Inc.
9.13.1 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Basic Information
9.13.2 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product Overview
9.13.3 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product Market Performance
9.13.4 Luc Therapeutics Inc. Business Overview
9.13.5 Luc Therapeutics Inc. Recent Developments
9.14 Evotec AG
9.14.1 Evotec AG Metabotropic Glutamate Antagonists Basic Information
9.14.2 Evotec AG Metabotropic Glutamate Antagonists Product Overview
9.14.3 Evotec AG Metabotropic Glutamate Antagonists Product Market Performance
9.14.4 Evotec AG Business Overview
9.14.5 Evotec AG Recent Developments
10 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET FORECAST BY REGION
10.1 Global Metabotropic Glutamate Antagonists Market Size Forecast
10.2 Global Metabotropic Glutamate Antagonists Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Metabotropic Glutamate Antagonists Market Size Forecast by Country
10.2.3 Asia Pacific Metabotropic Glutamate Antagonists Market Size Forecast by Region
10.2.4 South America Metabotropic Glutamate Antagonists Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Metabotropic Glutamate Antagonists by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Metabotropic Glutamate Antagonists Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Metabotropic Glutamate Antagonists by Type (2025-2030)
11.1.2 Global Metabotropic Glutamate Antagonists Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Metabotropic Glutamate Antagonists by Type (2025-2030)
11.2 Global Metabotropic Glutamate Antagonists Market Forecast by Application (2025-2030)
11.2.1 Global Metabotropic Glutamate Antagonists Sales (Kilotons) Forecast by Application
11.2.2 Global Metabotropic Glutamate Antagonists Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Metabotropic Glutamate Antagonists
1.2 Key Market Segments
1.2.1 Metabotropic Glutamate Antagonists Segment by Type
1.2.2 Metabotropic Glutamate Antagonists Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Metabotropic Glutamate Antagonists Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Metabotropic Glutamate Antagonists Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Metabotropic Glutamate Antagonists Sales by Manufacturers (2019-2024)
3.2 Global Metabotropic Glutamate Antagonists Revenue Market Share by Manufacturers (2019-2024)
3.3 Metabotropic Glutamate Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Metabotropic Glutamate Antagonists Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Metabotropic Glutamate Antagonists Sales Sites, Area Served, Product Type
3.6 Metabotropic Glutamate Antagonists Market Competitive Situation and Trends
3.6.1 Metabotropic Glutamate Antagonists Market Concentration Rate
3.6.2 Global 5 and 10 Largest Metabotropic Glutamate Antagonists Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 METABOTROPIC GLUTAMATE ANTAGONISTS INDUSTRY CHAIN ANALYSIS
4.1 Metabotropic Glutamate Antagonists Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF METABOTROPIC GLUTAMATE ANTAGONISTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Metabotropic Glutamate Antagonists Sales Market Share by Type (2019-2024)
6.3 Global Metabotropic Glutamate Antagonists Market Size Market Share by Type (2019-2024)
6.4 Global Metabotropic Glutamate Antagonists Price by Type (2019-2024)
7 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Metabotropic Glutamate Antagonists Market Sales by Application (2019-2024)
7.3 Global Metabotropic Glutamate Antagonists Market Size (M USD) by Application (2019-2024)
7.4 Global Metabotropic Glutamate Antagonists Sales Growth Rate by Application (2019-2024)
8 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET SEGMENTATION BY REGION
8.1 Global Metabotropic Glutamate Antagonists Sales by Region
8.1.1 Global Metabotropic Glutamate Antagonists Sales by Region
8.1.2 Global Metabotropic Glutamate Antagonists Sales Market Share by Region
8.2 North America
8.2.1 North America Metabotropic Glutamate Antagonists Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Metabotropic Glutamate Antagonists Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Metabotropic Glutamate Antagonists Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Metabotropic Glutamate Antagonists Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Metabotropic Glutamate Antagonists Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Artemis Neuroscience
9.1.1 Artemis Neuroscience Metabotropic Glutamate Antagonists Basic Information
9.1.2 Artemis Neuroscience Metabotropic Glutamate Antagonists Product Overview
9.1.3 Artemis Neuroscience Metabotropic Glutamate Antagonists Product Market Performance
9.1.4 Artemis Neuroscience Business Overview
9.1.5 Artemis Neuroscience Metabotropic Glutamate Antagonists SWOT Analysis
9.1.6 Artemis Neuroscience Recent Developments
9.2 VistaGen Therapeutics
9.2.1 VistaGen Therapeutics Metabotropic Glutamate Antagonists Basic Information
9.2.2 VistaGen Therapeutics Metabotropic Glutamate Antagonists Product Overview
9.2.3 VistaGen Therapeutics Metabotropic Glutamate Antagonists Product Market Performance
9.2.4 VistaGen Therapeutics Business Overview
9.2.5 VistaGen Therapeutics Metabotropic Glutamate Antagonists SWOT Analysis
9.2.6 VistaGen Therapeutics Recent Developments
9.3 Rottapharm Madaus
9.3.1 Rottapharm Madaus Metabotropic Glutamate Antagonists Basic Information
9.3.2 Rottapharm Madaus Metabotropic Glutamate Antagonists Product Overview
9.3.3 Rottapharm Madaus Metabotropic Glutamate Antagonists Product Market Performance
9.3.4 Rottapharm Madaus Metabotropic Glutamate Antagonists SWOT Analysis
9.3.5 Rottapharm Madaus Business Overview
9.3.6 Rottapharm Madaus Recent Developments
9.4 Amorsa Therapeutics
9.4.1 Amorsa Therapeutics Metabotropic Glutamate Antagonists Basic Information
9.4.2 Amorsa Therapeutics Metabotropic Glutamate Antagonists Product Overview
9.4.3 Amorsa Therapeutics Metabotropic Glutamate Antagonists Product Market Performance
9.4.4 Amorsa Therapeutics Business Overview
9.4.5 Amorsa Therapeutics Recent Developments
9.5 Newron Pharmaceuticals
9.5.1 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Basic Information
9.5.2 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product Overview
9.5.3 Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product Market Performance
9.5.4 Newron Pharmaceuticals Business Overview
9.5.5 Newron Pharmaceuticals Recent Developments
9.6 Purdue Biopharma
9.6.1 Purdue Biopharma Metabotropic Glutamate Antagonists Basic Information
9.6.2 Purdue Biopharma Metabotropic Glutamate Antagonists Product Overview
9.6.3 Purdue Biopharma Metabotropic Glutamate Antagonists Product Market Performance
9.6.4 Purdue Biopharma Business Overview
9.6.5 Purdue Biopharma Recent Developments
9.7 Relmada Therapeutics
9.7.1 Relmada Therapeutics Metabotropic Glutamate Antagonists Basic Information
9.7.2 Relmada Therapeutics Metabotropic Glutamate Antagonists Product Overview
9.7.3 Relmada Therapeutics Metabotropic Glutamate Antagonists Product Market Performance
9.7.4 Relmada Therapeutics Business Overview
9.7.5 Relmada Therapeutics Recent Developments
9.8 BioCrea GmbH
9.8.1 BioCrea GmbH Metabotropic Glutamate Antagonists Basic Information
9.8.2 BioCrea GmbH Metabotropic Glutamate Antagonists Product Overview
9.8.3 BioCrea GmbH Metabotropic Glutamate Antagonists Product Market Performance
9.8.4 BioCrea GmbH Business Overview
9.8.5 BioCrea GmbH Recent Developments
9.9 Cerecor Inc.
9.9.1 Cerecor Inc. Metabotropic Glutamate Antagonists Basic Information
9.9.2 Cerecor Inc. Metabotropic Glutamate Antagonists Product Overview
9.9.3 Cerecor Inc. Metabotropic Glutamate Antagonists Product Market Performance
9.9.4 Cerecor Inc. Business Overview
9.9.5 Cerecor Inc. Recent Developments
9.10 NeurOp Inc.
9.10.1 NeurOp Inc. Metabotropic Glutamate Antagonists Basic Information
9.10.2 NeurOp Inc. Metabotropic Glutamate Antagonists Product Overview
9.10.3 NeurOp Inc. Metabotropic Glutamate Antagonists Product Market Performance
9.10.4 NeurOp Inc. Business Overview
9.10.5 NeurOp Inc. Recent Developments
9.11 UCB SA
9.11.1 UCB SA Metabotropic Glutamate Antagonists Basic Information
9.11.2 UCB SA Metabotropic Glutamate Antagonists Product Overview
9.11.3 UCB SA Metabotropic Glutamate Antagonists Product Market Performance
9.11.4 UCB SA Business Overview
9.11.5 UCB SA Recent Developments
9.12 Novartis AG
9.12.1 Novartis AG Metabotropic Glutamate Antagonists Basic Information
9.12.2 Novartis AG Metabotropic Glutamate Antagonists Product Overview
9.12.3 Novartis AG Metabotropic Glutamate Antagonists Product Market Performance
9.12.4 Novartis AG Business Overview
9.12.5 Novartis AG Recent Developments
9.13 Luc Therapeutics Inc.
9.13.1 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Basic Information
9.13.2 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product Overview
9.13.3 Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product Market Performance
9.13.4 Luc Therapeutics Inc. Business Overview
9.13.5 Luc Therapeutics Inc. Recent Developments
9.14 Evotec AG
9.14.1 Evotec AG Metabotropic Glutamate Antagonists Basic Information
9.14.2 Evotec AG Metabotropic Glutamate Antagonists Product Overview
9.14.3 Evotec AG Metabotropic Glutamate Antagonists Product Market Performance
9.14.4 Evotec AG Business Overview
9.14.5 Evotec AG Recent Developments
10 METABOTROPIC GLUTAMATE ANTAGONISTS MARKET FORECAST BY REGION
10.1 Global Metabotropic Glutamate Antagonists Market Size Forecast
10.2 Global Metabotropic Glutamate Antagonists Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Metabotropic Glutamate Antagonists Market Size Forecast by Country
10.2.3 Asia Pacific Metabotropic Glutamate Antagonists Market Size Forecast by Region
10.2.4 South America Metabotropic Glutamate Antagonists Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Metabotropic Glutamate Antagonists by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Metabotropic Glutamate Antagonists Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Metabotropic Glutamate Antagonists by Type (2025-2030)
11.1.2 Global Metabotropic Glutamate Antagonists Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Metabotropic Glutamate Antagonists by Type (2025-2030)
11.2 Global Metabotropic Glutamate Antagonists Market Forecast by Application (2025-2030)
11.2.1 Global Metabotropic Glutamate Antagonists Sales (Kilotons) Forecast by Application
11.2.2 Global Metabotropic Glutamate Antagonists Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Metabotropic Glutamate Antagonists Market Size Comparison by Region (M USD)
Table 5. Global Metabotropic Glutamate Antagonists Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Metabotropic Glutamate Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Metabotropic Glutamate Antagonists Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Metabotropic Glutamate Antagonists Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Antagonists as of 2022)
Table 10. Global Market Metabotropic Glutamate Antagonists Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Metabotropic Glutamate Antagonists Sales Sites and Area Served
Table 12. Manufacturers Metabotropic Glutamate Antagonists Product Type
Table 13. Global Metabotropic Glutamate Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Metabotropic Glutamate Antagonists
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Metabotropic Glutamate Antagonists Market Challenges
Table 22. Global Metabotropic Glutamate Antagonists Sales by Type (Kilotons)
Table 23. Global Metabotropic Glutamate Antagonists Market Size by Type (M USD)
Table 24. Global Metabotropic Glutamate Antagonists Sales (Kilotons) by Type (2019-2024)
Table 25. Global Metabotropic Glutamate Antagonists Sales Market Share by Type (2019-2024)
Table 26. Global Metabotropic Glutamate Antagonists Market Size (M USD) by Type (2019-2024)
Table 27. Global Metabotropic Glutamate Antagonists Market Size Share by Type (2019-2024)
Table 28. Global Metabotropic Glutamate Antagonists Price (USD/Ton) by Type (2019-2024)
Table 29. Global Metabotropic Glutamate Antagonists Sales (Kilotons) by Application
Table 30. Global Metabotropic Glutamate Antagonists Market Size by Application
Table 31. Global Metabotropic Glutamate Antagonists Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Metabotropic Glutamate Antagonists Sales Market Share by Application (2019-2024)
Table 33. Global Metabotropic Glutamate Antagonists Sales by Application (2019-2024) & (M USD)
Table 34. Global Metabotropic Glutamate Antagonists Market Share by Application (2019-2024)
Table 35. Global Metabotropic Glutamate Antagonists Sales Growth Rate by Application (2019-2024)
Table 36. Global Metabotropic Glutamate Antagonists Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Metabotropic Glutamate Antagonists Sales Market Share by Region (2019-2024)
Table 38. North America Metabotropic Glutamate Antagonists Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Metabotropic Glutamate Antagonists Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Metabotropic Glutamate Antagonists Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Metabotropic Glutamate Antagonists Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Metabotropic Glutamate Antagonists Sales by Region (2019-2024) & (Kilotons)
Table 43. Artemis Neuroscience Metabotropic Glutamate Antagonists Basic Information
Table 44. Artemis Neuroscience Metabotropic Glutamate Antagonists Product Overview
Table 45. Artemis Neuroscience Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Artemis Neuroscience Business Overview
Table 47. Artemis Neuroscience Metabotropic Glutamate Antagonists SWOT Analysis
Table 48. Artemis Neuroscience Recent Developments
Table 49. VistaGen Therapeutics Metabotropic Glutamate Antagonists Basic Information
Table 50. VistaGen Therapeutics Metabotropic Glutamate Antagonists Product Overview
Table 51. VistaGen Therapeutics Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. VistaGen Therapeutics Business Overview
Table 53. VistaGen Therapeutics Metabotropic Glutamate Antagonists SWOT Analysis
Table 54. VistaGen Therapeutics Recent Developments
Table 55. Rottapharm Madaus Metabotropic Glutamate Antagonists Basic Information
Table 56. Rottapharm Madaus Metabotropic Glutamate Antagonists Product Overview
Table 57. Rottapharm Madaus Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Rottapharm Madaus Metabotropic Glutamate Antagonists SWOT Analysis
Table 59. Rottapharm Madaus Business Overview
Table 60. Rottapharm Madaus Recent Developments
Table 61. Amorsa Therapeutics Metabotropic Glutamate Antagonists Basic Information
Table 62. Amorsa Therapeutics Metabotropic Glutamate Antagonists Product Overview
Table 63. Amorsa Therapeutics Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Amorsa Therapeutics Business Overview
Table 65. Amorsa Therapeutics Recent Developments
Table 66. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Basic Information
Table 67. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product Overview
Table 68. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Newron Pharmaceuticals Business Overview
Table 70. Newron Pharmaceuticals Recent Developments
Table 71. Purdue Biopharma Metabotropic Glutamate Antagonists Basic Information
Table 72. Purdue Biopharma Metabotropic Glutamate Antagonists Product Overview
Table 73. Purdue Biopharma Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Purdue Biopharma Business Overview
Table 75. Purdue Biopharma Recent Developments
Table 76. Relmada Therapeutics Metabotropic Glutamate Antagonists Basic Information
Table 77. Relmada Therapeutics Metabotropic Glutamate Antagonists Product Overview
Table 78. Relmada Therapeutics Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Relmada Therapeutics Business Overview
Table 80. Relmada Therapeutics Recent Developments
Table 81. BioCrea GmbH Metabotropic Glutamate Antagonists Basic Information
Table 82. BioCrea GmbH Metabotropic Glutamate Antagonists Product Overview
Table 83. BioCrea GmbH Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. BioCrea GmbH Business Overview
Table 85. BioCrea GmbH Recent Developments
Table 86. Cerecor Inc. Metabotropic Glutamate Antagonists Basic Information
Table 87. Cerecor Inc. Metabotropic Glutamate Antagonists Product Overview
Table 88. Cerecor Inc. Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Cerecor Inc. Business Overview
Table 90. Cerecor Inc. Recent Developments
Table 91. NeurOp Inc. Metabotropic Glutamate Antagonists Basic Information
Table 92. NeurOp Inc. Metabotropic Glutamate Antagonists Product Overview
Table 93. NeurOp Inc. Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. NeurOp Inc. Business Overview
Table 95. NeurOp Inc. Recent Developments
Table 96. UCB SA Metabotropic Glutamate Antagonists Basic Information
Table 97. UCB SA Metabotropic Glutamate Antagonists Product Overview
Table 98. UCB SA Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. UCB SA Business Overview
Table 100. UCB SA Recent Developments
Table 101. Novartis AG Metabotropic Glutamate Antagonists Basic Information
Table 102. Novartis AG Metabotropic Glutamate Antagonists Product Overview
Table 103. Novartis AG Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Recent Developments
Table 106. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Basic Information
Table 107. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product Overview
Table 108. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Luc Therapeutics Inc. Business Overview
Table 110. Luc Therapeutics Inc. Recent Developments
Table 111. Evotec AG Metabotropic Glutamate Antagonists Basic Information
Table 112. Evotec AG Metabotropic Glutamate Antagonists Product Overview
Table 113. Evotec AG Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Evotec AG Business Overview
Table 115. Evotec AG Recent Developments
Table 116. Global Metabotropic Glutamate Antagonists Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Metabotropic Glutamate Antagonists Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Metabotropic Glutamate Antagonists Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Metabotropic Glutamate Antagonists Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Metabotropic Glutamate Antagonists Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Metabotropic Glutamate Antagonists Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Metabotropic Glutamate Antagonists Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Metabotropic Glutamate Antagonists Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Metabotropic Glutamate Antagonists Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Metabotropic Glutamate Antagonists Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Metabotropic Glutamate Antagonists Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Metabotropic Glutamate Antagonists Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Metabotropic Glutamate Antagonists Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Metabotropic Glutamate Antagonists Market Size Comparison by Region (M USD)
Table 5. Global Metabotropic Glutamate Antagonists Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Metabotropic Glutamate Antagonists Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Metabotropic Glutamate Antagonists Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Metabotropic Glutamate Antagonists Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Antagonists as of 2022)
Table 10. Global Market Metabotropic Glutamate Antagonists Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Metabotropic Glutamate Antagonists Sales Sites and Area Served
Table 12. Manufacturers Metabotropic Glutamate Antagonists Product Type
Table 13. Global Metabotropic Glutamate Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Metabotropic Glutamate Antagonists
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Metabotropic Glutamate Antagonists Market Challenges
Table 22. Global Metabotropic Glutamate Antagonists Sales by Type (Kilotons)
Table 23. Global Metabotropic Glutamate Antagonists Market Size by Type (M USD)
Table 24. Global Metabotropic Glutamate Antagonists Sales (Kilotons) by Type (2019-2024)
Table 25. Global Metabotropic Glutamate Antagonists Sales Market Share by Type (2019-2024)
Table 26. Global Metabotropic Glutamate Antagonists Market Size (M USD) by Type (2019-2024)
Table 27. Global Metabotropic Glutamate Antagonists Market Size Share by Type (2019-2024)
Table 28. Global Metabotropic Glutamate Antagonists Price (USD/Ton) by Type (2019-2024)
Table 29. Global Metabotropic Glutamate Antagonists Sales (Kilotons) by Application
Table 30. Global Metabotropic Glutamate Antagonists Market Size by Application
Table 31. Global Metabotropic Glutamate Antagonists Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Metabotropic Glutamate Antagonists Sales Market Share by Application (2019-2024)
Table 33. Global Metabotropic Glutamate Antagonists Sales by Application (2019-2024) & (M USD)
Table 34. Global Metabotropic Glutamate Antagonists Market Share by Application (2019-2024)
Table 35. Global Metabotropic Glutamate Antagonists Sales Growth Rate by Application (2019-2024)
Table 36. Global Metabotropic Glutamate Antagonists Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Metabotropic Glutamate Antagonists Sales Market Share by Region (2019-2024)
Table 38. North America Metabotropic Glutamate Antagonists Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Metabotropic Glutamate Antagonists Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Metabotropic Glutamate Antagonists Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Metabotropic Glutamate Antagonists Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Metabotropic Glutamate Antagonists Sales by Region (2019-2024) & (Kilotons)
Table 43. Artemis Neuroscience Metabotropic Glutamate Antagonists Basic Information
Table 44. Artemis Neuroscience Metabotropic Glutamate Antagonists Product Overview
Table 45. Artemis Neuroscience Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Artemis Neuroscience Business Overview
Table 47. Artemis Neuroscience Metabotropic Glutamate Antagonists SWOT Analysis
Table 48. Artemis Neuroscience Recent Developments
Table 49. VistaGen Therapeutics Metabotropic Glutamate Antagonists Basic Information
Table 50. VistaGen Therapeutics Metabotropic Glutamate Antagonists Product Overview
Table 51. VistaGen Therapeutics Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. VistaGen Therapeutics Business Overview
Table 53. VistaGen Therapeutics Metabotropic Glutamate Antagonists SWOT Analysis
Table 54. VistaGen Therapeutics Recent Developments
Table 55. Rottapharm Madaus Metabotropic Glutamate Antagonists Basic Information
Table 56. Rottapharm Madaus Metabotropic Glutamate Antagonists Product Overview
Table 57. Rottapharm Madaus Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Rottapharm Madaus Metabotropic Glutamate Antagonists SWOT Analysis
Table 59. Rottapharm Madaus Business Overview
Table 60. Rottapharm Madaus Recent Developments
Table 61. Amorsa Therapeutics Metabotropic Glutamate Antagonists Basic Information
Table 62. Amorsa Therapeutics Metabotropic Glutamate Antagonists Product Overview
Table 63. Amorsa Therapeutics Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Amorsa Therapeutics Business Overview
Table 65. Amorsa Therapeutics Recent Developments
Table 66. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Basic Information
Table 67. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Product Overview
Table 68. Newron Pharmaceuticals Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Newron Pharmaceuticals Business Overview
Table 70. Newron Pharmaceuticals Recent Developments
Table 71. Purdue Biopharma Metabotropic Glutamate Antagonists Basic Information
Table 72. Purdue Biopharma Metabotropic Glutamate Antagonists Product Overview
Table 73. Purdue Biopharma Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Purdue Biopharma Business Overview
Table 75. Purdue Biopharma Recent Developments
Table 76. Relmada Therapeutics Metabotropic Glutamate Antagonists Basic Information
Table 77. Relmada Therapeutics Metabotropic Glutamate Antagonists Product Overview
Table 78. Relmada Therapeutics Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Relmada Therapeutics Business Overview
Table 80. Relmada Therapeutics Recent Developments
Table 81. BioCrea GmbH Metabotropic Glutamate Antagonists Basic Information
Table 82. BioCrea GmbH Metabotropic Glutamate Antagonists Product Overview
Table 83. BioCrea GmbH Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. BioCrea GmbH Business Overview
Table 85. BioCrea GmbH Recent Developments
Table 86. Cerecor Inc. Metabotropic Glutamate Antagonists Basic Information
Table 87. Cerecor Inc. Metabotropic Glutamate Antagonists Product Overview
Table 88. Cerecor Inc. Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Cerecor Inc. Business Overview
Table 90. Cerecor Inc. Recent Developments
Table 91. NeurOp Inc. Metabotropic Glutamate Antagonists Basic Information
Table 92. NeurOp Inc. Metabotropic Glutamate Antagonists Product Overview
Table 93. NeurOp Inc. Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. NeurOp Inc. Business Overview
Table 95. NeurOp Inc. Recent Developments
Table 96. UCB SA Metabotropic Glutamate Antagonists Basic Information
Table 97. UCB SA Metabotropic Glutamate Antagonists Product Overview
Table 98. UCB SA Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. UCB SA Business Overview
Table 100. UCB SA Recent Developments
Table 101. Novartis AG Metabotropic Glutamate Antagonists Basic Information
Table 102. Novartis AG Metabotropic Glutamate Antagonists Product Overview
Table 103. Novartis AG Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Recent Developments
Table 106. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Basic Information
Table 107. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Product Overview
Table 108. Luc Therapeutics Inc. Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Luc Therapeutics Inc. Business Overview
Table 110. Luc Therapeutics Inc. Recent Developments
Table 111. Evotec AG Metabotropic Glutamate Antagonists Basic Information
Table 112. Evotec AG Metabotropic Glutamate Antagonists Product Overview
Table 113. Evotec AG Metabotropic Glutamate Antagonists Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Evotec AG Business Overview
Table 115. Evotec AG Recent Developments
Table 116. Global Metabotropic Glutamate Antagonists Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Metabotropic Glutamate Antagonists Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Metabotropic Glutamate Antagonists Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Metabotropic Glutamate Antagonists Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Metabotropic Glutamate Antagonists Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Metabotropic Glutamate Antagonists Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Metabotropic Glutamate Antagonists Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Metabotropic Glutamate Antagonists Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Metabotropic Glutamate Antagonists Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Metabotropic Glutamate Antagonists Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Metabotropic Glutamate Antagonists Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Metabotropic Glutamate Antagonists Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Metabotropic Glutamate Antagonists Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Metabotropic Glutamate Antagonists Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Metabotropic Glutamate Antagonists
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Metabotropic Glutamate Antagonists Market Size (M USD), 2019-2030
Figure 5. Global Metabotropic Glutamate Antagonists Market Size (M USD) (2019-2030)
Figure 6. Global Metabotropic Glutamate Antagonists Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Metabotropic Glutamate Antagonists Market Size by Country (M USD)
Figure 11. Metabotropic Glutamate Antagonists Sales Share by Manufacturers in 2023
Figure 12. Global Metabotropic Glutamate Antagonists Revenue Share by Manufacturers in 2023
Figure 13. Metabotropic Glutamate Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Metabotropic Glutamate Antagonists Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Metabotropic Glutamate Antagonists Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Metabotropic Glutamate Antagonists Market Share by Type
Figure 18. Sales Market Share of Metabotropic Glutamate Antagonists by Type (2019-2024)
Figure 19. Sales Market Share of Metabotropic Glutamate Antagonists by Type in 2023
Figure 20. Market Size Share of Metabotropic Glutamate Antagonists by Type (2019-2024)
Figure 21. Market Size Market Share of Metabotropic Glutamate Antagonists by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Metabotropic Glutamate Antagonists Market Share by Application
Figure 24. Global Metabotropic Glutamate Antagonists Sales Market Share by Application (2019-2024)
Figure 25. Global Metabotropic Glutamate Antagonists Sales Market Share by Application in 2023
Figure 26. Global Metabotropic Glutamate Antagonists Market Share by Application (2019-2024)
Figure 27. Global Metabotropic Glutamate Antagonists Market Share by Application in 2023
Figure 28. Global Metabotropic Glutamate Antagonists Sales Growth Rate by Application (2019-2024)
Figure 29. Global Metabotropic Glutamate Antagonists Sales Market Share by Region (2019-2024)
Figure 30. North America Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Metabotropic Glutamate Antagonists Sales Market Share by Country in 2023
Figure 32. U.S. Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Metabotropic Glutamate Antagonists Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Metabotropic Glutamate Antagonists Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Metabotropic Glutamate Antagonists Sales Market Share by Country in 2023
Figure 37. Germany Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Metabotropic Glutamate Antagonists Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Metabotropic Glutamate Antagonists Sales Market Share by Region in 2023
Figure 44. China Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Metabotropic Glutamate Antagonists Sales and Growth Rate (Kilotons)
Figure 50. South America Metabotropic Glutamate Antagonists Sales Market Share by Country in 2023
Figure 51. Brazil Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Metabotropic Glutamate Antagonists Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Metabotropic Glutamate Antagonists Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Metabotropic Glutamate Antagonists Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Metabotropic Glutamate Antagonists Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Metabotropic Glutamate Antagonists Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Metabotropic Glutamate Antagonists Market Share Forecast by Type (2025-2030)
Figure 65. Global Metabotropic Glutamate Antagonists Sales Forecast by Application (2025-2030)
Figure 66. Global Metabotropic Glutamate Antagonists Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Metabotropic Glutamate Antagonists
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Metabotropic Glutamate Antagonists Market Size (M USD), 2019-2030
Figure 5. Global Metabotropic Glutamate Antagonists Market Size (M USD) (2019-2030)
Figure 6. Global Metabotropic Glutamate Antagonists Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Metabotropic Glutamate Antagonists Market Size by Country (M USD)
Figure 11. Metabotropic Glutamate Antagonists Sales Share by Manufacturers in 2023
Figure 12. Global Metabotropic Glutamate Antagonists Revenue Share by Manufacturers in 2023
Figure 13. Metabotropic Glutamate Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Metabotropic Glutamate Antagonists Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Metabotropic Glutamate Antagonists Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Metabotropic Glutamate Antagonists Market Share by Type
Figure 18. Sales Market Share of Metabotropic Glutamate Antagonists by Type (2019-2024)
Figure 19. Sales Market Share of Metabotropic Glutamate Antagonists by Type in 2023
Figure 20. Market Size Share of Metabotropic Glutamate Antagonists by Type (2019-2024)
Figure 21. Market Size Market Share of Metabotropic Glutamate Antagonists by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Metabotropic Glutamate Antagonists Market Share by Application
Figure 24. Global Metabotropic Glutamate Antagonists Sales Market Share by Application (2019-2024)
Figure 25. Global Metabotropic Glutamate Antagonists Sales Market Share by Application in 2023
Figure 26. Global Metabotropic Glutamate Antagonists Market Share by Application (2019-2024)
Figure 27. Global Metabotropic Glutamate Antagonists Market Share by Application in 2023
Figure 28. Global Metabotropic Glutamate Antagonists Sales Growth Rate by Application (2019-2024)
Figure 29. Global Metabotropic Glutamate Antagonists Sales Market Share by Region (2019-2024)
Figure 30. North America Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Metabotropic Glutamate Antagonists Sales Market Share by Country in 2023
Figure 32. U.S. Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Metabotropic Glutamate Antagonists Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Metabotropic Glutamate Antagonists Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Metabotropic Glutamate Antagonists Sales Market Share by Country in 2023
Figure 37. Germany Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Metabotropic Glutamate Antagonists Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Metabotropic Glutamate Antagonists Sales Market Share by Region in 2023
Figure 44. China Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Metabotropic Glutamate Antagonists Sales and Growth Rate (Kilotons)
Figure 50. South America Metabotropic Glutamate Antagonists Sales Market Share by Country in 2023
Figure 51. Brazil Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Metabotropic Glutamate Antagonists Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Metabotropic Glutamate Antagonists Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Metabotropic Glutamate Antagonists Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Metabotropic Glutamate Antagonists Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Metabotropic Glutamate Antagonists Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Metabotropic Glutamate Antagonists Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Metabotropic Glutamate Antagonists Market Share Forecast by Type (2025-2030)
Figure 65. Global Metabotropic Glutamate Antagonists Sales Forecast by Application (2025-2030)
Figure 66. Global Metabotropic Glutamate Antagonists Market Share Forecast by Application (2025-2030)
